Home › The Outlook For Biotech M&A
 

Keywords :   


The Outlook For Biotech M&A

2015-09-19 00:23:08| Biotech - Topix.net

Merger and acquisition activity in the pharmaceutical and biotech sectors has been robust this year and is approaching levels not seen in a decade. There are myriad reasons to believe this trend will continue including low financing rates and the need to replace revenues from blockbusters losing patent protection in the next few years.

Tags: ma outlook biotech

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.05'Garden floods show need to work with nature'
03.05Worst-ever job interviews: 'We had to crawl and moo'
03.05Have the wheels come off for Tesla?
03.05BW Converting focuses on time, energy and cost savings at INFOFLEX
03.05Navigator Paper Ups Offer for Accrual
03.05USDA urged to restore NASS surveys
03.05Dilo Hosts Open House
03.05Spate Releases Top-Rising Skin Care Ingredients Report with Grant Industries
More »